These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 23596225)
21. Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy. Hoffman KE; Nguyen PL; Ng AK; D'Amico AV J Urol; 2010 May; 183(5):1798-802. PubMed ID: 20299039 [TBL] [Abstract][Full Text] [Related]
22. Prostate cancer in the serum prostate-specific antigen era. Humphrey PA Mayo Clin Proc; 1998 May; 73(5):489-90. PubMed ID: 9581595 [No Abstract] [Full Text] [Related]
23. American Cancer Society guideline for the early detection of prostate cancer: update 2010. Wolf AM; Wender RC; Etzioni RB; Thompson IM; D'Amico AV; Volk RJ; Brooks DD; Dash C; Guessous I; Andrews K; DeSantis C; Smith RA; CA Cancer J Clin; 2010; 60(2):70-98. PubMed ID: 20200110 [TBL] [Abstract][Full Text] [Related]
27. PSA-based screening for prostate cancer. Too many adverse effects. Prescrire Int; 2012 Sep; 21(130):215-7. PubMed ID: 23016259 [TBL] [Abstract][Full Text] [Related]
28. Prostate specific antigen and screening for early prostate cancer. Davidson P N Z Med J; 2001 Apr; 114(1129):150. PubMed ID: 11400919 [No Abstract] [Full Text] [Related]
29. [Mass screening for prostate cancer is the best approach to early diagnosis and treatment of prostate cancer]. Zhao XJ; Kong XB; Wang WH Zhonghua Nan Ke Xue; 2003 Nov; 9(8):563-5, 568. PubMed ID: 14689882 [TBL] [Abstract][Full Text] [Related]
30. First year of mass screening for prostatic cancer in Yaizu city. Kawabe K; Ishikawa A Aktuelle Urol; 2003 Jul; 34(4):242-3. PubMed ID: 14566673 [TBL] [Abstract][Full Text] [Related]
31. Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America. Colli JL; Amling CL Prostate Cancer Prostatic Dis; 2008; 11(3):247-51. PubMed ID: 18268527 [TBL] [Abstract][Full Text] [Related]
32. Prostate cancer--the snowball is rolling. Ruutu M; Salo J; Nordling S; Rannikko S Ann Chir Gynaecol; 1999; 88(1):5-8. PubMed ID: 10230675 [No Abstract] [Full Text] [Related]
33. Could prostate biopsies be avoided in men older than 75 years with raised PSA? Nomikos M; Mariappan P; Zachou A; McNeill A; Bollina PR Urol Int; 2010; 85(4):410-4. PubMed ID: 20962505 [TBL] [Abstract][Full Text] [Related]
34. Screening for prostate cancer: recommendations and rationale. Berg AO; Am J Nurs; 2003 Mar; 103(3):107-10; discussion 111. PubMed ID: 12626949 [No Abstract] [Full Text] [Related]
35. Upcoming evidences on prostate-specific antigen-based screening for men at risk of prostate cancer. Boscolo-Berto R Int J Urol; 2009 Sep; 16(9):711. PubMed ID: 19769655 [No Abstract] [Full Text] [Related]
39. How can rates of prostate-specific antigen screening be reduced in men aged 80 and older? Whittle J; Zablocki CJ J Am Geriatr Soc; 2010 Apr; 58(4):757-9. PubMed ID: 20398158 [No Abstract] [Full Text] [Related]
40. [Diagnosis based on prostate needle biopsy: inadequate correlation between pathologic results and clinical course for individual prognosis]. van der Kwast TH; Hoedemaeker RF; Schröder FH Ned Tijdschr Geneeskd; 2005 Apr; 149(18):972-6. PubMed ID: 15903037 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]